Alessio Cantore

University of Siena — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

20h-index2.6kcitations64works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(42), CRISPR and Genetic Engineering(19), RNA Interference and Gene Delivery(16), CAR-T cell therapy research(11), Viral Infectious Diseases and Gene Expression in Insects(11)

Publications64 total

Tweaking lentiviral vector design balances efficacy and safety in liver-directed gene therapy for familial hypercholesterolemia
Molecular Therapy·2025
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties
Nature Communications·2025Open Access
Spatiotemporal liver dynamics shape hepatocellular heterogeneity and impact in vivo gene engineering
Journal of Hepatology·2025· 3 citedOpen Access
POS1321 ATRIOVENTRICULAR CONDUCTION IN CHRONIC INFLAMMATORY ARTHRITIS: ENHANCED ASSESSMENT BY NEW ELECTROCARDIOGRAPHIC PARAMETERS
Annals of the Rheumatic Diseases·2025Open Access
ABS0510 ACUTE EFFECT OF ANTI-TNF THERAPY ON ATRIOVENTRICULAR CONDUCTION IN CHRONIC INFLAMMATORY ARTHRITIS: A PROSPECTIVE COHORT STUDY
Annals of the Rheumatic Diseases·2025Open Access
In vivo haemopoietic stem cell gene therapy enabled by postnatal trafficking
Nature·2025· 9 citedOpen Access
Enhancing the potency of in vivo lentiviral vector mediated gene therapy to hepatocytes
Nature Communications·2025· 9 citedOpen Access
OS-009 Tumor size-dependent endothelial switch modulates CD8+ T cell immune surveillance in liver cancer
Journal of Hepatology·2025
Clinical perspective: Advancing hemophilia treatment through gene therapy approaches
Molecular Therapy·2025· 5 citedOpen Access
Liver fibrosis negatively impacts in vivo gene transfer to murine hepatocytes
Nature Communications·2025· 6 citedOpen Access
Identification of hepatocyte-primed cholangiocytes in the homeostatic liver by in vivo lentiviral gene transfer to mice and non-human primates
Cell Reports·2025· 3 citedOpen Access
Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells
EMBO Reports·2024· 8 citedOpen Access
In vivo liver targeted genome editing as therapeutic approach: progresses and challenges
Frontiers in Genome Editing·2024· 8 citedOpen Access
Low-density lipoproteins receptor (LDLR) liver gene therapy normalizes LDL cholesterol (LDL-C) and prevents atherosclerosis in a familial hypercholesterolemia (FH) mouse model
Atherosclerosis·2024· 1 citedOpen Access
GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice
EMBO Molecular Medicine·2024· 14 citedOpen Access
GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice
2024
GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice
2024
Liver fibrosis negatively impacts in vivo gene transfer to hepatocytes
2024· 1 citedOpen Access
LSpECifying transgene expression
Molecular Therapy — Nucleic Acids·2024Open Access
Spatio-temporal dynamics of the liver shapes hepatocytes heterogeneity and impacts in vivo gene transfer and editing
Research Square (Research Square)·2023· 1 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Luigi Naldini(32), Andrea Annoni(16), Michela Milani(15), Mauro Biffi(15), Fabio Russo(14), Francesca Sanvito(12), Thierry VandenDriessche(10), Eugenio Montini(10), Francesco Starinieri(9), Lucia Sergi Sergi(8), Monica Volpin(8), Anna Fabiano(8), Patrizia Della Valle(7), Armando D’Angelo(7), Marinee Chuah(7), Timothy C. Nichols(7), Sara Bartolaccini(7), Angelo Lombardo(6), Chiara Brombin(6), Cesare Canepari(6)